Table: Garna Biosciences -2018 group results

Carna Biosciences

08/02/2019 06:30

Feb 8 (Reuters)- 
          Garna Biosciences Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended      Year ended        Year to         NEXT   
               Dec 31, 2018    Dec 31, 2017     Dec 31, 2019      YEAR     
                  LATEST         YEAR-AGO         COMPANY        COMPANY   
                 RESULTS          RESULTS         FORECAST     H1 FORECAST 
  Sales          754 mln          657 mln           1.24                   
               (+14.8 pct)      (-19.0 pct)     (+64.3 pct)                
  Operating     loss 1.14      loss 699 mln      loss 1.66                 
  Recurring     loss 1.16      loss 711 mln      loss 1.67                 
  Net
  Net           loss 1.21      loss 737 mln      loss 1.69                 
  EPS        loss 125.02 yen  loss 78.53 yen  loss 166.03 yen              
  Ann Div          NIL              NIL             NIL                    
  -Q2 Div          NIL              NIL             NIL                    
  -Q4 Div          NIL              NIL             NIL                    
  
  NOTE - Garna Biosciences Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T